Plasmakoncentrationer af aprepitant opnået efter 3 - dages behandlingsregime med EMEND forventes at optage mere end 95% af hjernens NK1 - receptorer.
Aprepitant plasma concentrations achieved with the 3- day regimen of EMEND are predicted to provide greater than 95% occupancy of brain NK1 receptors.